|
81
|
298
|
2r3mA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
79
|
279
|
2r0uA |
Crystal structure of chek1 in complex with inhibitor 54 |
|
110
|
349
|
2rg6A |
Phenylalanine pyrrolotriazine p38 alpha map kinase inhibitor compound 11j |
|
65
|
285
|
2rf9A |
Crystal structure of the complex between the egfr kinase domain and a mig6 peptide |
|
83
|
298
|
2r3iA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
84
|
298
|
2r3fA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
87
|
298
|
2r3hA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
79
|
298
|
2r3kA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
83
|
298
|
2r3oA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
84
|
298
|
2r3rA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
92
|
316
|
2r0iA |
Crystal structure of a kinase mark2/par-1 mutant |
|
79
|
298
|
2r64A |
Crystal structure of a 3-aminoindazole compound with cdk2 |
|
81
|
298
|
2r3gA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
86
|
298
|
2r3qA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
96
|
340
|
2qurA |
Crystal structure of f327a/k285p mutant of camp-dependent protein kinase |
|
87
|
338
|
2qvsE |
Crystal structure of type iia holoenzyme of camp-dependent protein kinase |
|
90
|
310
|
2qolA |
Human epha3 kinase and juxtamembrane region, y596:y602:s768g triple mutant |
|
82
|
297
|
2r5tA |
Crystal structure of inactive serum and glucocorticoid- regulated kinase 1 in complex with amp-pnp |
|
85
|
298
|
2r4bA |
Erbb4 kinase domain complexed with a thienopyrimidine inhibitor |
|
94
|
305
|
2qu5A |
Crystal structure of the vegfr2 kinase domain in complex with a benzimidazole inhibitor |
|
91
|
311
|
2qonA |
Human epha3 kinase and juxtamembrane region, y596f:y602f:y742a triple mutant |
|
200
|
677
|
2pziA |
Crystal structure of protein kinase pkng from mycobacterium tuberculosis in complex with tetrahydrobenzothiophene ax20017 |
|
97
|
312
|
2qu6A |
Crystal structure of the vegfr2 kinase domain in complex with a benzoxazole inhibitor |
|
85
|
298
|
2qr7A |
2.0a x-ray structure of c-terminal kinase domain of p90 ribosomal s6 kinase 2: se-met derivative |
|
90
|
310
|
2qo2A |
Human epha3 kinase and juxtamembrane region, dephosphorylated, apo structure |
|
90
|
298
|
2qr8A |
2.0a x-ray structure of c-terminal kinase domain of p90 ribosomal s6 kinase 2 (rsk2) |
|
88
|
312
|
2qoqA |
Human epha3 kinase and juxtamembrane region, base, amp-pnp bound structure |
|
74
|
292
|
2qkwB |
Structural basis for activation of plant immunity by bacterial effector protein avrpto |
|
108
|
348
|
2qd9A |
P38 alpha map kinase inhibitor based on heterobicyclic scaffolds |
|
93
|
298
|
2pwlA |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic n549h mutation responsible for crouzon syndrome. |
|
90
|
299
|
2pvfA |
Crystal structure of tyrosine phosphorylated activated fgf receptor 2 (fgfr2) kinase domain in complex with atp analog and substrate peptide |
|
89
|
310
|
2qodA |
Human epha3 kinase and juxtamembrane region, y602f mutant |
|
70
|
278
|
2qlqA |
Crystal structure of src kinase domain with covalent inhibitor rl3 |
|
112
|
327
|
2qc6A |
Protein kinase ck2 in complex with dbc |
|
93
|
294
|
2qocA |
Human epha3 kinase domain, phosphorylated, amp-pnp bound structure |
|
113
|
327
|
2pvjA |
Structure-based design of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase ck2 |
|
88
|
310
|
2qokA |
Human epha3 kinase and juxtamembrane region, y596f:y602f:s768a triple mutant |
|
69
|
296
|
2qkrA |
Cryptosporidium parvum cyclin-dependent kinase cgd5_2510 with indirubin 3'-monoxime bound |
|
84
|
285
|
2qg5A |
Cryptosporidium parvum calcium dependent protein kinase cgd7_1840 |
|
90
|
310
|
2qo7A |
Human epha3 kinase and juxtamembrane region, dephosphorylated, amp-pnp bound |
|
110
|
328
|
2pvhA |
Structure-based design of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase ck2 |
|
97
|
324
|
2qnjA |
Kinase and ubiquitin-associated domains of mark3/par-1 |
|
101
|
348
|
2puuA |
Crystal structure of p38 complex with 1-(5-tert-butyl-2-p-tolyl-2h-pyrazol-3-yl)-3-[4-(6-morpholin-4-ylmethyl-pyridin-3-yl)naphthalen-1-yl]urea |
|
91
|
297
|
2qo9A |
Human epha3 kinase and juxtamembrane region, phosphorylated, amp-pnp bound |
|
82
|
279
|
2qhnA |
Crystal structure of chek1 in complex with inhibitor 1a |
|
75
|
277
|
2qi8A |
Crystal structure of drug resistant src kinase domain |
|
91
|
312
|
2qofA |
Human epha3 kinase and juxtamembrane region, y596f mutant |
|
109
|
328
|
2pvnA |
Structure-based design of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase ck2 |
|
73
|
277
|
2qq7A |
Crystal structure of drug resistant src kinase domain with irreversible inhibitor |
|
94
|
298
|
2qobA |
Human epha3 kinase domain, base structure |
